rs145970332
Positions:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 2P and 8B. PM2BP4_ModerateBP6BP7BS1
The NM_001082538.3(TCTN1):c.960C>T(p.Cys320Cys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000613 in 1,614,202 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00048 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00063 ( 1 hom. )
Consequence
TCTN1
NM_001082538.3 synonymous
NM_001082538.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 3.47
Genes affected
TCTN1 (HGNC:26113): (tectonic family member 1) This gene encodes a member of a family of secreted and transmembrane proteins. The orthologous gene in mouse functions downstream of smoothened and rab23 to modulate hedgehog signal transduction. This protein is a component of the tectonic-like complex, which forms a barrier between the ciliary axoneme and the basal body. A mutation in this gene was found in a family with Joubert syndrome-13. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]
HVCN1 (HGNC:28240): (hydrogen voltage gated channel 1) This gene encodes a voltage-gated protein channel protein expressed more highly in certain cells of the immune system. Phagocytic cells produce superoxide anions which require this channel protein, and in B cells this same process facilitates antibody production. This same channel protein, however, can also regulate functions in other cells including spermatozoa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44).
BP6
Variant 12-110640499-C-T is Benign according to our data. Variant chr12-110640499-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 307208.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=2, Uncertain_significance=1}. Variant chr12-110640499-C-T is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=3.47 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.000479 (73/152320) while in subpopulation NFE AF= 0.000647 (44/68036). AF 95% confidence interval is 0.000495. There are 0 homozygotes in gnomad4. There are 33 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCTN1 | NM_001082538.3 | c.960C>T | p.Cys320Cys | synonymous_variant | 8/15 | ENST00000397659.9 | NP_001076007.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCTN1 | ENST00000397659.9 | c.960C>T | p.Cys320Cys | synonymous_variant | 8/15 | 1 | NM_001082538.3 | ENSP00000380779.4 | ||
TCTN1 | ENST00000551590.5 | c.960C>T | p.Cys320Cys | synonymous_variant | 8/15 | 1 | ENSP00000448735.1 | |||
TCTN1 | ENST00000397655.7 | c.918C>T | p.Cys306Cys | synonymous_variant | 8/15 | 1 | ENSP00000380775.3 | |||
TCTN1 | ENST00000397656.8 | n.*593C>T | non_coding_transcript_exon_variant | 9/16 | 2 | ENSP00000380776.4 | ||||
TCTN1 | ENST00000480648.5 | n.*236C>T | non_coding_transcript_exon_variant | 9/16 | 5 | ENSP00000437196.1 | ||||
TCTN1 | ENST00000495659.6 | n.*718C>T | non_coding_transcript_exon_variant | 8/15 | 2 | ENSP00000436673.2 | ||||
TCTN1 | ENST00000397656.8 | n.*593C>T | 3_prime_UTR_variant | 9/16 | 2 | ENSP00000380776.4 | ||||
TCTN1 | ENST00000480648.5 | n.*236C>T | 3_prime_UTR_variant | 9/16 | 5 | ENSP00000437196.1 | ||||
TCTN1 | ENST00000495659.6 | n.*718C>T | 3_prime_UTR_variant | 8/15 | 2 | ENSP00000436673.2 |
Frequencies
GnomAD3 genomes AF: 0.000480 AC: 73AN: 152202Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
73
AN:
152202
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000789 AC: 197AN: 249602Hom.: 0 AF XY: 0.000702 AC XY: 95AN XY: 135402
GnomAD3 exomes
AF:
AC:
197
AN:
249602
Hom.:
AF XY:
AC XY:
95
AN XY:
135402
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000627 AC: 916AN: 1461882Hom.: 1 Cov.: 31 AF XY: 0.000624 AC XY: 454AN XY: 727238
GnomAD4 exome
AF:
AC:
916
AN:
1461882
Hom.:
Cov.:
31
AF XY:
AC XY:
454
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000479 AC: 73AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.000443 AC XY: 33AN XY: 74484
GnomAD4 genome
AF:
AC:
73
AN:
152320
Hom.:
Cov.:
32
AF XY:
AC XY:
33
AN XY:
74484
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Joubert syndrome 13 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
TCTN1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 08, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Meckel-Gruber syndrome;C0431399:Familial aplasia of the vermis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Feb 11, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at